Cellcure Medicare Private Limited
About Cellcure Medicare Private Limited
Data last updated:
Cellcure Medicare Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Cellcure Cancer Centre Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the preventive healthcare segment of the healthcare sector. It was incorporated on 19 December 2017.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2017PTC303080.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Vashista Pankaj Maniar and Ashish Anand Joshi.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 1st Floor Khodiyar Apt Chsl Daulat Nagar Raod No. 6 Borivali East, Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2023, the company reported a revenue of ₹7.89 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Cr (net margin 22.8%) and EBITDA of ₹2.59 Cr (EBITDA margin 32.8%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 104% over five years.
The company had about 13 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: MOC India.
Company details
Contact details
Cellcure Medicare Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1st Floor Khodiyar Apt Chsl Daulat Nagar Raod No. 6 Borivali East, Mumbai, Maharashtra, India – 400066
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Cellcure Medicare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cellcure Medicare operates one associated brand: MOC India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology and hematology services are delivered via clinic chains. | mocindia.co.in |
Business activity
The main business activity of Cellcure Medicare is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Cellcure Medicare Private Limited, buy the company report.
Financials of Cellcure Medicare Private Limited
FY 2023 filings availableCellcure Medicare Private Limited reported revenue of ₹7.89 Cr (up 40% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 104% over five years, including 40% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.89 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.8% | ||||
| Net Profit Margin | 22.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cellcure Medicare Private Limited, buy the company report.
Board of directors of Cellcure Medicare Private Limited
Cellcure Medicare has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vashista Pankaj Maniar Also directs: Cellcure Cancer Centre Private Limited, Moc Cancer Care Foundation | Director | 19 Dec 2017 | 8 Years 10 Months | As last reported |
| Ashish Anand Joshi Also directs: Cellcure Cancer Centre Private Limited, Moc Cancer Care Foundation | Director | 19 Dec 2017 | 8 Years 10 Months | As last reported |
| Kshitij Chandrakant Joshi Also directs: Cellcure Cancer Centre Private Limited, Moc Cancer Care Foundation, Sameforever Private Limited and 1 more | Director | 19 Dec 2017 | 8 Years 10 Months | As last reported |
| Preetam Baban Kalaskar Also directs: Cellcure Cancer Centre Private Limited, Moc Cancer Care Foundation, Sameforever Private Limited and 1 more | Director | 19 Dec 2017 | 8 Years 10 Months | As last reported |
Peer comparison
Cellcure Medicare Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nestiva Medicare Private Limited | ₹7.92 Cr (FY 2022) | -17.0% | New Delhi, Delhi, India | |||
| Functional Medicine Institute Private Limited | ₹7.91 Cr (FY 2024) | 70.0% | Bengaluru, Karnataka, India | |||
| Seven Sigma Healthcare Solutions Private Limited | ₹7.9 Cr (FY 2024) | 18.0% | Perinthalmanna, Kerala, India | |||
| Cellcure Medicare Private Limitedthis company | ₹7.89 Cr (FY 2023) | ₹1.8 Cr | 22.8% | 40.0% | 13 | Mumbai, Maharashtra, India |
| Primex Healthcare and Research Private Limited | ₹7.87 Cr (FY 2024) | 9.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Cellcure Medicare Private Limited, buy the company report.
Auditor
Cellcure Medicare Private Limited is audited by P.L.Raval & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.L.Raval & Co | FY 2023 | 031888 |
Shareholding
The shareholding of Cellcure Medicare Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cellcure Medicare Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cellcure Medicare Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Cellcure Medicare Private Limited has 9 MSME Form 1 returns on record between 2019 and 2023, listing 130 overdue payments to 28 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 28)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Karkinos Healthcare Private Limited | |||
| Unipath Specialty Laboratory Limited | |||
| Core Diagnostics Private Limited | |||
| Qualilife Dignostics | |||
| Elderberry Diagnostic LLP |
To see the full MSME payment records of Cellcure Medicare Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Cellcure Medicare Private Limited has a workforce of 13 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
No GST registration is on our record for Cellcure Medicare Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cellcure Medicare Private Limited has 8 board changes on record since 2017: 4 appointments and 4 cessations. The latest: Ashish Anand Joshi ceased to be Director on 27 Apr 2021.
Frequently asked questions
Cellcure Medicare has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Cellcure Medicare was a private limited company based in Mumbai, Maharashtra, India. The company worked in preventive health services, within the healthcare industry. It was incorporated on 19 December 2017 and is registered under CIN U74999MH2017PTC303080. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Cellcure Medicare was incorporated on 19 December 2017. It is registered with the Registrar of Companies, Mumbai.
Cellcure Medicare had 4 directors:
- Vashista Pankaj Maniar - Director
- Ashish Anand Joshi - Director
- Kshitij Chandrakant Joshi - Director
- Preetam Baban Kalaskar - Director
The CIN (Corporate Identification Number) of Cellcure Medicare is U74999MH2017PTC303080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Cellcure Medicare is at 1st Floor Khodiyar Apt Chsl Daulat Nagar Raod No. 6 Borivali East, Mumbai, Maharashtra, India – 400066.
The latest financial statements of Cellcure Medicare on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
Cellcure Medicare operated in the healthcare industry, in the preventive health services segment.
The peers of Cellcure Medicare by revenue are Nestiva Medicare Private Limited, Functional Medicine Institute Private Limited, Seven Sigma Healthcare Solutions Private Limited, Primex Healthcare and Research Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities).
Cellcure Medicare has 9 MSME Form 1 returns on record between 2019 and 2023, listing 130 overdue payments to 28 micro and small suppliers. The latest return was filed on 15 Dec 2023.
Ashish Anand Joshi ceased to be Director on 27 Apr 2021. Preetam Baban Kalaskar ceased to be Director on 27 Apr 2021. Kshitij Chandrakant Joshi ceased to be Director on 31 Mar 2021. Cellcure Medicare has 8 board changes on record in total.
The compliance status of Cellcure Medicare is compliant as of 14 September 2026.